Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/NJ/Newark
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Newark, NJ

Studies commonly pay $75 to $4,500 per completed study

4,236 clinical trials are currently recruiting participants within 30 miles of Newark. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

4,236studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Newark right now

Top 25 of 4,236 recruiting studies, sorted by proximity — each links to its official registry page

Acupuncture for People Experiencing Period Loss Due to Chemotherapy

Cancer, Period Problem Phase 2 Interventional 60 participants sought
Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York (8.7 mi) · Sponsor: Memorial Sloan Kettering Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT06915116)

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

HER2-positive Metastatic Breast Cancer N/A Observational 200 participants sought
Montefiore Einstein Medical Center — The Bronx, New York (18.2 mi) · Sponsor: Abramson Cancer Center at Penn Medicine
See eligibility & contact on ClinicalTrials.gov (NCT06551116)

A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma

Plasma Cell Myeloma Refractory Phase 1 Interventional 87 participants sought
Hackensack Meridian Health - Hackensack University Medical Center- Site Number : 8400001 — Hackensack, New Jersey (13.0 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT06630806)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health — New York, New York (8.7 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Envision Ocular, LLC — Bloomfield, New Jersey (5.7 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Follicular Lymphoma, Lymphoma Phase 2 Interventional 152 participants sought
Memorial Sloan Kettering Cancer Center — New York, New York (8.7 mi) · Sponsor: Memorial Sloan Kettering Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT05389293)

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Solid Tumor, Non-Small-Cell Lung Cancer Phase 1 Interventional 364 participants sought
Memorial Sloan Kettering Cancer Center — New York, New York (8.7 mi) · Sponsor: Astellas Pharma Inc
See eligibility & contact on ClinicalTrials.gov (NCT07094204)

Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts

Aortic Aneurysm, Thoracoabdominal, Aortic Aneurysm, Thoracic N/A Interventional 520 participants sought
New York Presbyterian Hospital — New York, New York (8.7 mi) · Sponsor: Darren Schneider, M.D.
See eligibility & contact on ClinicalTrials.gov (NCT02323581)

Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors

Smoking Cessation N/A Interventional 50 participants sought
Institute for Nicotine & Tobacco Studies — New Brunswick, New Jersey (22.0 mi) · Sponsor: Rutgers, The State University of New Jersey
See eligibility & contact on ClinicalTrials.gov (NCT07210567)

Study of Aerobic Training for People Receiving Treatment for Breast Cancer

Breast Cancer, Breast Carcinoma Phase 2 Interventional 140 participants sought
Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York (8.7 mi) · Sponsor: Memorial Sloan Kettering Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT05716893)

A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)

Ovarian Cancer Recurrent Phase 1, Phase 2 Interventional 460 participants sought
Memorial Sloan Kettering Cancer Center ( Site 0003) — New York, New York (8.7 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06843447)

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Solid Tumor Cancer, Locally Advanced Phase 1, Phase 2 Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — New York, New York (8.7 mi) · Sponsor: Avenzo Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07038343)

A Study of Multiparametric Ultrasound Imaging Methods

Pancreatic Cancer, Thyroid Nodule N/A Interventional 85 participants sought
Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York (8.7 mi) · Sponsor: Memorial Sloan Kettering Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT07270237)

A Study of a Urine Test to Detect Colorectal Cancer

Colorectal Cancer, Precancerous Polyp N/A Observational 210 participants sought
Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York (8.7 mi) · Sponsor: Memorial Sloan Kettering Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT07649057)

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma Phase 1, Phase 2 Interventional 260 participants sought
Memorial Sloan Kettering Cancer Center — New York, New York (8.7 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT05372354)

Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery

Metastatic Colon Carcinoma, Stage IV Colon Cancer AJCC v8 Phase 2 Interventional 42 participants sought
The Cancer Center — Newark, New Jersey (0.8 mi) · Sponsor: Howard S. Hochster, MD
See eligibility & contact on ClinicalTrials.gov (NCT05296681)

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

Adult Congenital Heart Disease, Congenital Heart Disease N/A Observational 400 participants sought
Mount Sinai Fuster Heart Hospital — New York, New York (8.7 mi) · Sponsor: Leiden University Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT06932081)

Can Stories Encourage the Elderly to Vaccinate? Combining Viewer-tailored Personal Narrative Videos With Informational Videos to Improve Vaccine Uptake Among Older Adults

Vaccination N/A Interventional 6,000 participants sought
Ipsos — New York, New York (8.7 mi) · Sponsor: Johns Hopkins Bloomberg School of Public Health
See eligibility & contact on ClinicalTrials.gov (NCT06890403)

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Phase 1 Interventional 248 participants sought
Memorial Sloan Kettering Cancer Center — New York, New York (8.7 mi) · Sponsor: Nurix Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04830137)

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma Phase 3 Interventional 1,524 participants sought
Memorial Sloan Kettering Cancer Center — New York, New York (8.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07200830)
Google-rated

Top-rated research centers in Newark

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Biotrial Inc.

★ 4.5
130 Norfolk St, Newark, NJ 07103
(844) 246-8459
"I’m curious what kind of studies do you offer?cosmetics,back patches?"
— Iman Thompson, 5★

Med Clinical Research

★ 5.0 (1 reviews)
40 Union Ave #206, Irvington, NJ 07111
(908) 798-8373

Inflamax Research

★ 3.5
228 Lafayette St, Newark, NJ 07105
(888) 989-1808
"A nicer facilty and better food than most places. Also, for the particular study I did there the pay was good. Although, it was the 2nd most disorgan…"
— Yancy Smith, 3★

CARDIOVASCULAR CLINICAL RESEARCH UNIT

201 Lyons Ave, Newark, NJ 07112
(973) 926-6938

Hudson County Clinical Trials Research Center

★ 5.0
The Monastery First floor, 1901 West St, Union City, NJ 07087
(201) 345-2101
"Went there for an H pylori study and they were very knowledgeable and professional , will participate in future studies"
— EMILIO FERNANDEZ, 5★

North Jersey Community Research Initiative

★ 4.2
393 Central Ave, Newark, NJ 07103
(973) 483-3444
"The best clinic out here I swear love this place everyone deserves a raise 😭🥰"
— nicky fefe, 5★

New Jersey Clinical Research Center

★ 5.0 (1 reviews)
29 Park St APT 2, Montclair, NJ 07042
(973) 509-2001

DM Clinical Research — Jersey City

★ 4.9
1 Journal Square Plaza Ste 102, Jersey City, NJ 07306
(848) 999-5778
"Such an unfortunate experience. I came in excited for a Covid vaccine research study and was approved. They then went through multiple rounds of tryi…"
— Hannah Simpson, 1★

Circuit Clinical, Secaucus NJ

38 Meadowlands Pkwy #205, Secaucus, NJ 07094

Clinical trials in Newark: what's recruiting

The Newark area currently has 4,236 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Newark, the most active research areas are:

  • Cancer & Oncology15 studies
  • Diabetes & Metabolism2 studies
  • Heart & Vascular2 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Newark, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Newark

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Newark participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Newark pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Newark?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Newark safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Newark, NJ?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
How often do new paid studies open in Newark?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Newark.

Paid clinical trials near Newark

Other metros within reach

Jersey City, NJ4,298 Staten Island, NY4,243 Paterson, NJ4,113 Manhattan, NY4,173 Brooklyn, NY4,241 New York, NY4,179 Bronx, NY4,155 Queens, NY4,142

More of NJ

Jersey City4,298 Paterson4,113 Trenton2,343

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts